Please login to the form below

Not currently logged in
Email:
Password:

oxaliplatin

This page shows the latest oxaliplatin news and features for those working in and with pharma, biotech and healthcare.

Lilly’s pegilodecakin fails in long-shot pancreatic cancer trial

Lilly’s pegilodecakin fails in long-shot pancreatic cancer trial

In the SEQUOIA trial, pegilodecakin was added to the widely-used FOLFOX regimen (folinic acid, 5-fluorouracil and oxaliplatin) as second-line therapy for metastatic pancreatic cancer patients who had progressed

Latest news

More from news
Approximately 0 fully matching, plus 37 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

    PMHub

    Add my company
    Aptus Health

    Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

    Latest intelligence

    RWE Blog 3: Is real-world evidence the holy grail
    We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...
    What do Healthcare Professionals think about the inclusion of remote selling techniques?
    Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
    Drug pricing and competition
    Strengthening business competition and reducing anti-competitive practices
    How the CMA is tackling high prices for essential drugs...

    Infographics